- $8.44m
- $7.99m
- $16.00m
- 60
- 44
- 70
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 53.7 | 24.4 | 20 | 16.2 | 16 |
Cost of Revenue | |||||
Gross Profit | 35.1 | 11 | 8.82 | 5.55 | 7.08 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 70.9 | 47 | 35.5 | 22.9 | 12.6 |
Operating Profit | -17.2 | -22.6 | -15.5 | -6.72 | 3.36 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -17.2 | -22.6 | -15.6 | -8.26 | 3.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.6 | -22.3 | -15.6 | -8.21 | 3.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.6 | -22.3 | -15.6 | -8.21 | 3.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.6 | -22.3 | -15.6 | -9.13 | 3.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.17 | -0.223 | -0.126 | -0.058 | 0.022 |